Literature DB >> 19224478

Dexamethasone inner ear perfusion for subclinical endolymphatic hydrops.

Herbert Silverstein1, Mathew Farrugia, Mark Van Ess.   

Abstract

We suggest that the term subclinical cochlear hydrops be used to describe patients presenting with aural fullness, stuffiness, or ear pressure when all other diagnoses have been excluded. We reviewed the charts of 20 patients who had presented with a chief complaint of aural fullness, stuffiness, or pressure and who underwent perfusion of the inner ear for 1 month with dexamethasone 4 or 10 mg/ml. The symptoms improved in 13 (68.4%) of 19 patients after treatment. None of these patients reported a worsening of symptoms, and no patient had worse hearing after perfusion. Complications were infrequent, and patients tolerated the treatment well. Perfusion of the inner ear appears to be a safe procedure with little risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224478

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  2 in total

Review 1.  Endolymphatic hydrops mimicking obstructive Eustachian tube dysfunction: preliminary experience and literature review.

Authors:  David Bächinger; Andreas H Eckhard; Christof Röösli; Dorothe Veraguth; Alexander Huber; Adrian Dalbert
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-24       Impact factor: 2.503

2.  Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.

Authors:  Paul R Lambert; John Carey; Anthony A Mikulec; Carl LeBel
Journal:  Otol Neurotol       Date:  2016-12       Impact factor: 2.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.